Testing the Addition of a New Anti-Cancer Drug, Triapine, to the Usual Chemotherapy Treatment (Cisplatin) During Radiation Therapy for Advanced-stage Cervical and Vaginal Cancers
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Merck Sharp & Dohme LLC
University of Pittsburgh
Merck Sharp & Dohme LLC
Radiation Therapy Oncology Group
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Incyte Corporation
University of Virginia
GOG Foundation
Brown University
EpicentRx, Inc.
University of California, San Diego
M.D. Anderson Cancer Center
AstraZeneca
University of Miami
EMD Serono
National Cancer Institute (NCI)
Merck Sharp & Dohme LLC
Canadian Cancer Trials Group
Cantonal Hospital of St. Gallen
pharmaand GmbH
GOG Foundation
Incyte Corporation
GOG Foundation
AIDS Malignancy Consortium
Cedars-Sinai Medical Center
GOG Foundation
GOG Foundation
GOG Foundation
GOG Foundation
Children's Oncology Group
Abramson Cancer Center at Penn Medicine
National Institutes of Health Clinical Center (CC)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Taiho Pharmaceutical Co., Ltd.
Radiation Therapy Oncology Group
Montefiore Medical Center
GOG Foundation
GOG Foundation
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Western Regional Medical Center
University Hospital Tuebingen
GOG Foundation
Memorial Sloan Kettering Cancer Center
GOG Foundation
National Cancer Institute (NCI)
University of Oklahoma